CERO logo

CERO

Profile

Full Name

CERo Therapeutics Holdings, Inc.

Ticker Symbol

CERO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 30, 2021

Indexes

Not included

Website

http://www.cero.bio

Employees

8

Key Details

Price

$0.58(-13.56%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$130.44(-11.28% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.58
CERO price is $0.58

30-Day Relative Volume

1.19
CERO 30-day relative volume is 1.19

Price Performance

Price Today change

-13.56%
CERO price is down -13.56% today

Price YTD change

-90.33%
CERO price is down -90.33% since January 1st

Price 1-year change

-99.67%
CERO price is down -99.67% year-on-year

Price 3-year change

-99.94%
CERO price is down -99.94% over the past 3 years

Price Range

Price All-time high

$1132.00
CERO price is currently -99.95% below its historical high of $1132.00

Price 3-year low

$0.05
CERO price is currently +1134.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.76M
CERO market capitalization is $1.76 million

Market cap 3-year change

-
CERO market capitalization 3-year change is unknown

Market cap All-time high

$116.48M
CERO market capitalization is currently -98.49% below its historical high of $116.48 million

Market cap sector rank

6.09%
CERO market capitalization is higher than 6.09% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1958.36%
CERO shares outstanding is up +1958.36% year-on-year

Shares Outstanding 3-Year Change

-
CERO shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.69
CERO beta is 0.69

200-day SMA

$9.54
CERO price is currently -93.92% below its 200-day simple moving average

50-day SMA

$1.30
CERO price is currently -55.47% below its 50-day simple moving average

RSI

30.52
CERO 14-day relative strength index is 30.52

Volume

1.19
CERO 30-day relative volume is 1.19

ATR

$0.15
CERO average true range is $0.15

10-day Historical Volatility

121.87%
CERO 10-day historical volatility is 121.87%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CERO annual revenue value is unknown

Revenue Analysts estimate

-
CERO annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CERO annual revenue 1-year change is unknown

Revenue Sector rank

-
CERO annual revenue is unknown

EPS

EPS

-$130.44
CERO annual earnings per share is -$130.44

EPS Analysts estimate

-
CERO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-11.28%
CERO annual earnings per share is down -11.28% year-on-year

EPS Sector rank

1.82%
CERO annual earnings per share is higher than 1.82% of companies in Healthcare sector

Profit

Gross profit

-
CERO annual gross profit value is unknown

Gross margin

-
CERO annual gross profit margin value is unknown

Operating profit

-$11.97M
CERO annual operating income is -$11.97 million

Operating margin

-
CERO annual operating profit margin value is unknown

Net income

-$11.83M
CERO annual net profit is -$11.83 million

Net margin

-
CERO annual net profit margin value is unknown

Expenses

Total expenses

$11.97M
CERO annual total expenses is $11.97 million

Operating expenses

$11.97M
CERO annual total operating expenses is $11.97 million

Cost of goods sold

-
CERO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$2.13M
CERO annual SGA is $2.13 million

Depreciation and amortization

$1.07M
CERO annual depreciation & amortization is $1.07 million

Interest expense

-
CERO annual interest expense value is unknown

Income tax

-
CERO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$11.97M
CERO annual earnings before interest & taxes is -$11.97 million

EBITDA

-$10.90M
CERO annual EBITDA is -$10.90 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$11.35M
CERO annual total assets is $11.35 million

Non current assets

$4.27M
CERO annual long term assets is $4.27 million

Current assets

$7.08M
CERO annual total current assets is $7.08 million

Cash and cash equivalents

$6.82M
CERO annual cash & cash equivalents is $6.82 million

Accounts receivable

-
CERO annual accounts receivable value is unknown

Inventory

-
CERO annual inventory value is unknown

Liabilities

Total liabilities

$46.22M
CERO annual total liabilities is $46.22 million

Long term liabilities

$45.06M
CERO annual total long term liabilities is $45.06 million

Current liabilities

$1.16M
CERO annual total current liabilities is $1.16 million

Accounts payable

$391.20K
CERO annual accounts payable is $391.20 thousand

Debt

Total debt

$3.02M
CERO annual total debt is $3.02 million

Total debt 1-year change

-16.25%
CERO annual total debt is down -16.25% year-on-year

Long term debt

$2.34M
CERO annual long term debt is $2.34 million

Short term debt

$672.40K
CERO annual short term debt is $672.40 thousand

Equity & Capital

Shareholders equity

-$34.87M
CERO annual stockholders equity is -$34.87 million

Book value

-$34.87M
CERO annual book value is -$34.87 million

Retained earnings

-$35.80M
CERO annual retained earnings is -$35.80 million

Working capital

$5.91M
CERO annual working capital is $5.91 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.71M
CERO annual cash flow from operations is -$11.71 million

Cash from operations 1-year change

-16%
CERO annual cash flow from operations is down -16% year-on-year

Cash from investing

-$694.20K
CERO annual cash flow from investing activities is -$694.20 thousand

Cash from investing 1-year change

-13.32%
CERO annual cash flow from investing activities is down -13.32% year-on-year

Cash from financing

$5600.00
CERO annual cash flow from financing activities is $5600.00

Cash from financing 1-year change

-90.71%
CERO annual cash flow from financing activities is down -90.71% year-on-year

CAPEX

CAPEX

-
CERO annual capital expenditures value is unknown

CAPEX 1-year change

-
CERO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$12.40M
CERO annual free cash flow is -$12.40 million

Free cash flow 1-year change

-15.85%
CERO annual free cash flow is down -15.85% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CERO annual gross profit margin value is unknown

Operating margin

-
CERO annual operating profit margin value is unknown

Net margin

-
CERO annual net profit margin value is unknown

ROA & ROE

ROA

-104.23%
CERO annual return on assets is -104.23%

ROE

33.92%
CERO annual return on equity is 33.92%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CERO price to earnings ratio value is unknown

PE ratio Sector rank

-
CERO price to earnings ratio is unknown

PB Ratio

PB ratio

-0.24
CERO price to book ratio is -0.24

PB ratio Sector rank

11.52%
CERO price to book ratio is higher than 11.52% of companies in Healthcare sector

PS Ratio

PS ratio

-
CERO price to sales ratio value is unknown

PS ratio Sector rank

-
CERO price to sales ratio is unknown

Enterprise value

Enterprise value

$181.94K
CERO enterprise value is $181.94 thousand

Enterprise value Sector rank

12.15%
CERO enterprise value is higher than 12.15% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.03
CERO EV/EBITDA is -0.03

EV/EBITDA Sector rank

63.83%
CERO EV/EBITDA is higher than 63.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.08
CERO annual current ratio is 6.08

Quick ratio

-
CERO annual quick ratio value is unknown

Leverage

Debt to equity

-0.09
CERO annual debt to equity ratio is -0.09

Interest coverage ratio

-
CERO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CERO piotroski f-score value is unknown

Altman Z-Score

-
CERO altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

GRTX logo
Galera Therapeutics (GRTX)
AIM logo
AIM ImmunoTech (AIM)
FOXO logo
FOXO Technologies (FOXO)
EYEN logo
Eyenovia (EYEN)
ENTO logo
Entero Therapeutics (ENTO)
ZVSA logo
ZyVersa Therapeutics (ZVSA)
OMGA logo
Omega Therapeutics (OMGA)
VCNX logo
Vaccinex (VCNX)
PBM logo
Psyence Biomedical (PBM)
  • What is the ticker symbol for CERo Therapeutics Holdings?
  • Does CERo Therapeutics Holdings pay dividends?
  • What sector is CERo Therapeutics Holdings in?
  • What industry is CERo Therapeutics Holdings in?
  • What country is CERo Therapeutics Holdings based in?
  • When did CERo Therapeutics Holdings go public?
  • Is CERo Therapeutics Holdings in the S&P 500?
  • Is CERo Therapeutics Holdings in the NASDAQ 100?
  • Is CERo Therapeutics Holdings in the Dow Jones?
  • When does CERo Therapeutics Holdings report earnings?

What is the ticker symbol for CERo Therapeutics Holdings?

The ticker symbol for CERo Therapeutics Holdings is NASDAQ:CERO

Does CERo Therapeutics Holdings pay dividends?

No, CERo Therapeutics Holdings does not pay dividends

What sector is CERo Therapeutics Holdings in?

CERo Therapeutics Holdings is in the Healthcare sector

What industry is CERo Therapeutics Holdings in?

CERo Therapeutics Holdings is in the Biotechnology industry

What country is CERo Therapeutics Holdings based in?

CERo Therapeutics Holdings is headquartered in United States

When did CERo Therapeutics Holdings go public?

CERo Therapeutics Holdings's initial public offering (IPO) was on November 30, 2021

Is CERo Therapeutics Holdings in the S&P 500?

No, CERo Therapeutics Holdings is not included in the S&P 500 index

Is CERo Therapeutics Holdings in the NASDAQ 100?

No, CERo Therapeutics Holdings is not included in the NASDAQ 100 index

Is CERo Therapeutics Holdings in the Dow Jones?

No, CERo Therapeutics Holdings is not included in the Dow Jones index

When does CERo Therapeutics Holdings report earnings?

The date for CERo Therapeutics Holdings's next earnings report has not been announced yet
On this page